Mark Zuckerberg backs $500 million push to build AI models of human cells as part of long-term effort to cure disease.
In an interview with VentureBeat, Jean-Philippe Vert, co-founder and CEO of Bioptimus, chief R&D Officer of Owkin and former research lead at Google Brain, said as a smaller, independent company, ...